Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
1Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114,
2Medicinal Chemistry & Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea
Tel: +82-42-860-7176, Fax: +82-42-860-7160
Received: March 12, 2021; Revised: April 29, 2021; Accepted: May 7, 2021; Published online: June 2, 2021.
© The Korean Society of Applied Pharmacology. All rights reserved.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/
) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.